Literature DB >> 17257996

Surgical correction of tetralogy of Fallot with unilateral absence of pulmonary artery.

Leo A Bockeria1, Vladimir P Podzolkov, Osman A Makhachev, Mikhail A Zelenikin, Bagrat G Alekian, Vladimir N Ilyin, Ali A Gadjiev, Konstantin V Shatalov, Teya T Kakuchaya, Titalav Kh Khiriev, Sergey B Zaets.   

Abstract

BACKGROUND: Tetralogy of Fallot with unilateral absence of the pulmonary artery is a rare congenital heart defect that still represents a surgical challenge. The purpose of this study is to summarize our experience of surgical treatment of this complex lesion.
METHODS: From 1983 to 2003, 27 patients with tetralogy of Fallot and unilateral absence of the left (n = 25) or right (n = 2) pulmonary artery underwent different surgical interventions. The age of patients ranged from 40 days to 37 years (median, 5.3 years). Pulmonary arterial Nakata index and Nakata index Z-score were used for the quantitative assessment of the contralateral pulmonary artery. Twenty patients underwent various palliative procedures, namely Blalock-Taussig or Gore-Tex shunt, transluminal balloon pulmonary valvuloplasty, and reconstruction of right ventricular outflow tract without ventricular septal defect closure. At a median interval of 3.6 years after palliation, 13 patients underwent complete repair of tetralogy of Fallot. In the other 7 patients, complete repair was performed as a primary intervention.
RESULTS: Hospital mortality after palliation and after a complete repair was the same and reached 5%. Sixteen patients with the Nakata index greater than 200 mm2/m2 and Z-score greater than -4 survived after a complete repair. One of 4 patients with Nakata index less than 200 mm2/m2 and Z-score less than -4 died after surgery.
CONCLUSIONS: Majority of patients with tetralogy of Fallot and unilateral absence of the pulmonary artery require palliative intervention as a first step of surgical treatment. Nakata index greater than 200 mm2/m2 and Nakata index Z-score greater than -4 are criteria for a successful complete repair.

Entities:  

Mesh:

Year:  2007        PMID: 17257996     DOI: 10.1016/j.athoracsur.2006.08.022

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Unilateral absence of pulmonary artery with absent pulmonary valve in tetralogy of Fallot.

Authors:  Ashish Katewa; Shivang Saxena; Pulkit Malhotra; Venuthurupalli S P Rajesh; Bhavik Champaneri; Jigar Surti
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-09-06

2.  Palliative surgical treatment of congenital heart defects associated with unilateral absence of the pulmonary artery.

Authors:  Leo A Bockeria; Vladimir P Podzolkov; Osman A Makhachev; Bagrat G Alekyan; Titalav Kh Khiriev; Mikhail A Zelenikin; Konstantin V Shatalov; Sergey B Zaets
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-04

3.  A comprehensive study of congenital unilateral absence of branch pulmonary artery associated with other congenital heart defects and ipsilateral non-unifocalizable major aorto-pulmonary collateral arteries: A single-center retrospective study.

Authors:  Harpanahalli Ravi Ramamurthy; Varsha Walavalkar; Satheesh Siddaiah; Sunita Maheshwari
Journal:  Ann Pediatr Cardiol       Date:  2021-04-10

4.  Hidden pulmonary arteries in tetralogy of Fallot and pulmonary artery pressure in patients operated with a pulmonary artery.

Authors:  Mohammadreza Edraki; Bahram Ghasemzadeh; Kambiz Keshavarz; Ahmadali Amirghofran; Hamid Mohammadi; Zahra Kheirandish; Hamid Amoozgar; Elahe Nirooei; Gholamhossein Ajami; Nima Mehdizadegan; Amir Naghshzan; Farah Peiravian; Sirous Cheriki; Mohammad Javad Nobahkti
Journal:  BMC Cardiovasc Disord       Date:  2021-01-28       Impact factor: 2.298

5.  Fetal cardiac parameters for predicting postnatal operation type of fetuses with tetralogy of Fallot.

Authors:  Suyeon Park; Hye-Sung Won; Rina Kim; Mijin Kim; Jeong Jin Yu; Chun Soo Park; Tae-Jin Yun; Yewon Jung; Usamah Al Harbi; Mi-Young Lee
Journal:  Cardiovasc Ultrasound       Date:  2022-02-21       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.